ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,338Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 4623

$1.5M Total Retail Price of All Prescriptions

Rank: 39 out of 4623

844 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 844 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

38% of this provider’s 844 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 16,695 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 902 505 S3 1 3
LEVOTHYROXINE SODIUM 641 456 2 1
POTASSIUM CHLORIDE 558 412 3 14
SIMVASTATIN 510 375 4 2
PRAVASTATIN SODIUM 505 341 5 11
FUROSEMIDE 498 338 6 8
RANITIDINE HCL 497 299 7 47
DICLOFENAC POTASSIUM 457 257 8 247
WARFARIN SODIUM 455 341 9 24
AMLODIPINE BESYLATE 390 292 10 5
CARVEDILOL 369 288 11 25
LISINOPRIL 355 253 12 4
METFORMIN HCL 338 256 13 6
GABAPENTIN 337 233 14 16
FAMOTIDINE 318 262 15 82
SULFAMETHOXAZOLE-TRIMETHOPRIM 305 179 16 68
AMITRIPTYLINE HCL 303 130 R 17 69
OMEPRAZOLE 299 203 18 7
TAMSULOSIN HCL 296 248 19 29
CLONIDINE HCL 289 207 20 40
ALLOPURINOL 266 204 21 37
TRAMADOL HCL 253 183 22 15
PREDNISONE 229 149 23 50
METOPROLOL TARTRATE 214 151 24 9
TIZANIDINE HCL 198 95 25 111
METOPROLOL SUCCINATE 190 151 26 13
PENICILLIN V POTASSIUM 188 107 27 429
HYDROCHLOROTHIAZIDE 183 142 28 10
PANTOPRAZOLE SODIUM 176 135 29 35
PROMETHAZINE HCL 174 61 R 30 93
NIFEDIPINE ER 173 121 31 97
CEPHALEXIN 165 117 32 84
ADVAIR DISKUS 164 107 33 62
ROPINIROLE HCL 162 105 34 108
CLINDAMYCIN HCL 161 99 35 236
NAMENDA 160 156 36 36
LOSARTAN POTASSIUM 158 157 37 21
NEXIUM 155 61 38 17
DIGOXIN 151 133 39 58
DONEPEZIL HCL 151 141 39 30
CYMBALTA 150 87 41 48
ACETAMINOPHEN-CODEINE 149 89 S3 42 144
ZOLPIDEM TARTRATE 148 93 43 18
POLYETHYLENE GLYCOL 3350 144 104 44 91
ZETIA 136 101 45 92
ATENOLOL 135 95 46 28
SPIRONOLACTONE 134 93 47 77
HYDRALAZINE HCL 133 107 48 99
LANTUS 131 77 49 44
LYRICA 127 79 50 66
PROAIR HFA 116 65 51 64
CLOPIDOGREL 116 110 51 31
RAMIPRIL 115 99 53 76
ONGLYZA 114 87 54 192
DIOVAN 114 89 54 39
VERAPAMIL ER 113 74 56 96
LIDOCAINE HCL 112 88 57 271
VOLTAREN 112 83 57 182
PROPRANOLOL HCL 110 70 59 169
AMLODIPINE BESYLATE-BENAZEPRIL 109 77 60 55
SERTRALINE HCL 107 65 61 26
LEVETIRACETAM 106 94 62 114
ATORVASTATIN CALCIUM 105 80 63 12
BISOPROLOL-HYDROCHLOROTHIAZIDE 104 82 64 146
INDOMETHACIN 103 69 R 65 312
COLESTIPOL HCL 102 86 66 478
TRAZODONE HCL 100 64 67 42
VENTOLIN HFA 93 37 68 134
SPIRIVA 91 69 69 79
PRIMIDONE 89 66 70 260
FLUOXETINE HCL 88 67 71 61
DOXYCYCLINE HYCLATE 88 65 71 101
PLAVIX 85 74 73 45
IBUPROFEN 83 61 74 65
AVODART 82 73 75 172
INDAPAMIDE 81 53 76 286
ISOSORBIDE MONONITRATE ER 81 68 76 60
FLUCONAZOLE 80 46 78 189
SINGULAIR 77 47 79 83
SUCRALFATE 77 68 79 183
COLCRYS 76 57 81 310
GLIMEPIRIDE 76 64 81 38
LIDODERM 75 61 83 139
BENAZEPRIL HCL 74 61 84 70
VYTORIN 73 50 85 170
ESCITALOPRAM OXALATE 73 43 85 75
LANSOPRAZOLE 71 41 87 241
LANTUS SOLOSTAR 71 43 87 105
CIPROFLOXACIN HCL 70 49 89 43
IPRATROPIUM BROMIDE 69 48 90 216
BACLOFEN 68 0 91 133
METOCLOPRAMIDE HCL 68 45 91 126
VERAPAMIL HCL 68 60 91 339
DOXEPIN HCL 66 40 94 209
IPRATROPIUM-ALBUTEROL 64 57 95 177
MECLIZINE HCL 64 58 95 125
NIASPAN 62 50 97 110
NOVOLOG 62 37 97 123
CARISOPRODOL 62 23 R 97 71
DIPHENOXYLATE-ATROPINE 61 33 100 406
DIOVAN HCT 59 30 101 67
LABETALOL HCL 59 52 101 226
BUPROPION XL 58 20 103 219
CELEBREX 58 48 103 89
PEN NEEDLE 57 27 105 122
AMPICILLIN TRIHYDRATE 57 30 105 453
GLYBURIDE MICRONIZED 57 43 R 105 205
CITALOPRAM HBR 56 30 108 23
METOLAZONE 56 42 108 208
JANUVIA 56 43 108 52
EXELON 55 55 111 107
PHENYTOIN SODIUM EXTENDED 55 35 111 119
BUPROPION HCL SR 55 34 111 233
METFORMIN HCL ER 55 48 111 51
LOSARTAN-HYDROCHLOROTHIAZIDE 54 38 115 46
AGGRENOX 54 40 115 198
TOPIRAMATE 53 14 117 197
GENTAMICIN SULFATE 53 31 117 278
NIFEDICAL XL 52 38 119 239
SYMBICORT 51 34 120 151
MELOXICAM 51 38 120 27
NITROFURANTOIN 51 42 120 243
FLUTICASONE PROPIONATE 51 27 120 32
PAROXETINE HCL 51 41 120 78
QUETIAPINE FUMARATE 50 20 125 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 25, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.